CANIGEN DHА2PPi /LR, Lyophilisate and solvent for suspension for injection
CANIGEN DHА2PPi /LR, Lyophilisate and solvent for suspension for injection
Authorised
- Rabies virus, strain VP12, Inactivated
- Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
- Canine parainfluenza virus, strain Manhattan, Live
- Canine parvovirus, strain Cornell 780916, Live
- Canine adenovirus 2, strain Manhattan, Live
- Canine distemper virus, strain Lederle, Live
Product identification
Medicine name:
CANIGEN DHА2PPi /LR, Лиофилизат и разтворител за инжекционна суспензия
CANIGEN DHА2PPi /LR, Lyophilisate and solvent for suspension for injection
Active substance:
- Rabies virus, strain VP12, Inactivated
- Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
- Canine parainfluenza virus, strain Manhattan, Live
- Canine parvovirus, strain Cornell 780916, Live
- Canine adenovirus 2, strain Manhattan, Live
- Canine distemper virus, strain Lederle, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Rabies virus, strain VP12, Inactivated1.00/international unit(s)1.00Dose
-
Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated8.33/80% Protective Dose1.00Dose
-
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated8.33/80% Protective Dose1.00Dose
-
Canine parainfluenza virus, strain Manhattan, Live5.00/log10 50% cell culture infectious dose1.00Dose
-
Canine parvovirus, strain Cornell 780916, Live5.00/log10 50% cell culture infectious dose1.00Dose
-
Canine adenovirus 2, strain Manhattan, Live4.00/log10 50% cell culture infectious dose1.00Dose
-
Canine distemper virus, strain Lederle, Live3.00/log10 50% cell culture infectious dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AI01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-2296
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 23/05/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 23/05/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 23/05/2025